Image 1 of 1
2021-04-01-Manaus-0084.jpg
People wait in chairs before receiving the CoronaVac vaccine, also known as the Sinovac COVID-19 vaccine at Club Trabalhador/SESI in Manaus, Brazil March 30, 2021. CoronaVac is an inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech and has been in Brazil's Phase III clinical trials. Photo Ken Cedeno
